oxymetazoline has been researched along with Drop Attack in 2 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabi, M | 1 |
| Formigari, R | 1 |
| Picchio, FM | 1 |
| Glazener, F | 1 |
| Blake, K | 1 |
| Gradman, M | 1 |
2 other studies available for oxymetazoline and Drop Attack
| Article | Year |
|---|---|
Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.
Topics: Bradycardia; Diagnosis, Differential; Echocardiography; Electrocardiography; Humans; Infant; Male; N | 2009 |
Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray.
Topics: Aged; Bradycardia; Humans; Hypotension; Imidazoles; Male; Oxymetazoline; Syncope | 1983 |